NinaMED Pty Ltd: Clinical Trials

1 trial sponsored by NinaMED Pty Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Not yet recruiting 1

Follow NinaMED Pty Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder
Wearable neurostimulation system for saphenous nerve stimulation, tolterodine tartrate 4 mg extended release - Overactive Bladder (OAB)
Phase 3Not yet recruitingNinaMED Pty Ltd2902026-09-102026-08-24

Conditions studied

Urinary Bladder, Overactive (1)

Interventions

Tolterodine Tartrate (1)

Countries

Australia (1)  ·  United States (1)